Receptor for interleukin 13 on AIDS-associated Kaposi's sarcoma cells serves as a new target for a potent Pseudomonas exotoxin-based chimeric toxin protein

Clinical Cancer Research

Volumn 3, Issue 2, 1997, Pages 151-156

  Husain, Syed R ^a   Obiri, Nicholas I ^a   Gill, Parkash ^b   Zheng, Tong ^b   Pastan, Ira ^c   Debinski, Waldemar ^d   Puri, Raj K ^a  

^a CENTER FOR BIOLOGICS EVALUATION AND RESEARCH   (United States)

^b UNIVERSITY OF SOUTHERN CALIFORNIA   (United States)

^c NATIONAL CANCER INSTITUTE   (United States)

^d PENN STATE COLLEGE OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CHIMERIC PROTEIN; INTERLEUKIN 13 RECEPTOR; PSEUDOMONAS EXOTOXIN;

ACQUIRED IMMUNE DEFICIENCY SYNDROME; ARTICLE; CONTROLLED STUDY; DRUG CYTOTOXICITY; DRUG TARGETING; HUMAN; HUMAN CELL; KAPOSI SARCOMA; PRIORITY JOURNAL;

ADP RIBOSE TRANSFERASES; AIDS-RELATED OPPORTUNISTIC INFECTIONS; ANTINEOPLASTIC AGENTS; BACTERIAL TOXINS; EXOTOXINS; HUMANS; IMMUNOTOXINS; INTERLEUKIN-13; INTERLEUKIN-13 RECEPTOR ALPHA1 SUBUNIT; PROTEIN SYNTHESIS INHIBITORS; RECEPTORS, INTERLEUKIN; RECEPTORS, INTERLEUKIN-13; SARCOMA, KAPOSI; TUMOR CELLS, CULTURED; TUMOR STEM CELL ASSAY; VIRULENCE FACTORS;

EID: 0031029303     PISSN: 10780432     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (26)

1. Ensoli, B., and Gallo, R. C. Growth factors in AIDS-associated Kaposi's sarcoma: cytokines and HIV-1 tat protein. AIDS Updates, 5: 1-7, 1992.
2. Miles, S. A. Pathogenesis of HIV-related Kaposi's sarcoma. Curr. Opin. Oncol., 6: 497-502, 1994.
3. Ensoli, B., Nakamura, S., Salahuddin, S. Z., Biberfeld, P., Larson, L., Beaver, B., Wong-Staal, F., and Gallo, R. C. AIDS-Kaposi's sarcoma-derived cells express cytokines with autocrine and paracrine growth factors. Science (Washington DC), 243: 223-226, 1989.
4. Ganem, D. Viruses, cytokines and Kaposi's sarcoma. Curr. Biol., 5: 469-471, 1995.
5. Biberfeld, P., Nakamura, S., Ensoli, B., Salahuddin, S. Z., Barillari, G., Parravicini, C., Gendelman, R., Kaaya, E., and Gallo, R. C. Autocrine and paracrine mechanism in the evolution of Kaposi's sarcoma (KS). In: W. Westmark, C. Betsholtz, B. Hokfelt (eds.), Growth Factors in Health and Disease, pp. 277-280. New York: Elsevier Science Publishing Co., Inc., 1990.
6. Ensoli, B., Barillari, G., and Gallo, R. C. Cytokines and growth factors in the pathogenesis of AIDS-associated Kaposi's sarcoma. Immunol. Rev., 727: 147-155, 1992.
7. Barillari, G., Buonaguro, L., Fiorelli, V., Huffman, J., Michaels, F., Gallo, R. C., and Ensoli, B. Effects of cytokines from activated immune cells on vascular cell growth and HIV-1 gene expression. J. Immunol., 149: 3727-3734, 1992.
8. Miles, S. A., Rezai, A. R., Salazar-Gonzalez, J. F., Vander Meyden, M. Stevens, R. H., Logan, D. M., Mitsuyasu, R. T., Taga, T., Hirano, T., and Kishimoto, T. AIDS-Kaposi's sarcoma-derived cells produce and respond to interleukin 6. Proc. Natl. Acad. Sci. USA. 87: 4068-4072, 1990.
9. Ensoli, B., Gendelman, R., Markham, P., Fiorelli, V., Colombini, S., Raffeld, M., Cafaro, A., Chang, H-K. Brady, J. N., and Gallo, R. C. Synergy between basic fibroblast growth factor and HIV-1 tat protein in induction of Kaposi's sarcoma. Nature (Lond.), 371: 674-680, 1994.
10. Stürzl, M., Roth, W. K., Brockmeyer, N. H., Zietz, C., Speiser, B., and Hofschneider, P. H. Expression of platelet-derived growth factor and its receptor in AIDS-related Kaposi's sarcoma in vivo suggests paracrine and autocrine mechanisms of tumor maintenance. Proc. Natl. Acad. Sci. USA, 89: 7046-7050, 1992.
11. Gill, P., and Puri, R. K. Interleukin 4 receptor (IL-4R) expression on AIDS-related Kaposi's sarcoma (AIDS-KS) cells and inhibition of tumor cell growth and cytokine production by IL-4. Proc. Am. Assoc. Cancer Res., 34: 188, 1993.
12. Minty, A., Chalon, P., Derocq, J-M., Dumont, X., Guillemot, J-C., Kaghad, M., Labit, C., Leplatois, P., Liauzun, P., Miloux, B., Minty, P., Casellas, P., Loison, G., Lupker, J., Shire, D., Ferrara, P., and Caput, D. Interleukin-13 is a new human lymphokine regulating inflammatory and immune responses. Nature (Lond.), 362: 248-250, 1993.
13. Zurawski, G., and de Vries, J. E. Interleukin 13, an interleukin 4-like cytokine that acts on monocytes and B cells, but not on T cells. Immunol. Today, 15: 19-26, 1994.
14. Montaner, L. J., Doyle, A. G., Collin, M., Herbein, G., Illei, P., James, W., Minty, A., Caput, D., Ferrara, P., and Gordon, S. Interleukin 13 inhibits human immunodeficiency virus type 1 production in primary blood-derived human macrophages in vitro. J. Exp. Med., 178: 743-747, 1993.
15. Novak, R. M., Holzer, T. J., Kennedy, M. M., Heynen, C. A., and Dawson, G. The effect of interleukin-4 (BSF-1) on infection of peripheral blood monocyte-derived macrophages with HIV-I. AIDS Res. Hum. Retroviruses, 6: 973-976, 1990.
16. Obiri, N. I., Debinski, W., Leonard, W. J., and Puri, R. K. Receptors for interleukin 13: interaction with interleukin 4 by a mechanism that does not involve the common γ chain shared by receptors for interleukin 2, 4, 7, 9 and 15. J. Biol. Chem., 270: 8797-8804, 1995.
17. Zurawski, S. M., Vega, F., Hughe, B., and Zurawski, G. Receptors for interleukin-13 and interleukin-4 are complex and share a novel component that function in signal transduction. EMBO J., 12: 2663-2670, 1993.
18. Debinski, W., Obiri, N. I., Pastan, I., and Puri, R. K. A novel chimeric protein composed of interleukin 13 and Pseudomonas exotoxin is highly cytotoxic to human carcinoma cells expressing receptors for interleukin 13 and interleukin 4. J. Biol. Chem., 270: 16775-16780, 1995.
19. Debinski, W., Obiri, N. I. Powers, S. K., Pastan, I., and Puri, R. K. Human glioma cells overexpress receptors for interleukin 13 and are extremely sensitive to a novel chimeric protein composed of interleukin 13 and pseudomonas exotoxin. Clin. Cancer Res., 1: 1253-1258, 1995.
20. Puri, R. K., Leland, P., Obiri, N. I., Husain, S. R., Kreitman, R. J., Haas, G. P., Pastan, I., and Debinski, W. Targeting of interleukin-13 receptor on human renal cell carcinoma cells by a recombinant chimeric protein comprised of interleukin 13 and Pseudomonas exotoxin. Blood, 87: 4333-4339, 1996.
21. Masood, R., Husain, S. R., Rahman, A., and Gill, P. Potentiation of cytotoxicity of Kaposi's sarcoma related to immunodeficiency syndrome (AIDS) by liposome-encapsulated doxorubicin. AIDS Res. Hum. Retroviruses, 8: 741-746, 1993.
22. Bochner, B. S., Klunk, D. A., Sterbinsky, S. A., Coffman, R. L., and Schleimer, R. P. IL-13 selectively induces vascular cell adhesion molecule-1 expression in human endothelial cells. J. Immunol., 154: 799-803, 1995.
23. Obiri, N. I., Leland, P., Murata, T., Debinski, W., and Puri, R. K. The IL-13 receptor structure differs on various cell types and may share more than one component with IL-4 receptor. J. Immunol., in press, 1997.
24. Gross, J. L., Behrens, D. L., Mullins, D. E., Kornblith, P. L., Dexter, D. L. Plasminogen activator and inhibitor activity in human glioma cells and modulation by sodium butyrate. Cancer Res., 48: 291-296, 1988.
25. Freedman, V. H., and Shin, S. I. Cellular tumorigenicity in nude mice: correlation with cell growth in semi-solid medium. Cell, 3: 355-359, 1974.
26. Munson, P. J., and Rodbard, D. Ligand: a versatile computerized approach for characterization of ligand-binding systems. Anal. Biochem., 107: 220-239, 1980.